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Considering Innovative Alternatives to Handling Cases
of Adults with Special Conditions Under the Social
Security Act
By Sarah Robichaud *
ABSTRACT:
Title II and Title XVI of the Social Security Act provide critical
support to individuals with disabilities. However, until recently, the
way that the Social Security Administration processed medical
information to make disability determinations had not changed in any
fundamental way since the inception of the Act.
The disability determination process is logical for many
frequently handled, well-known conditions, yet there are a significant
number of cases regarding special conditions that are not as well-
known or as frequently considered by the Office of Disability
Adjudication and Review, which administers hearings and appeals
for the Social Security Administration.
The Social Security Administration is currently updating its
business model to ensure that people with special conditions receive
effective treatment during the disability hearing process. As a step
toward reaching this goal, the Social Security Administration
recently enacted Compassionate Allowances, a list of conclusively
presumptive disabilities.
* Ms. Robichaud currently serves as an attorney in the Office of Disability
Adjudication and Review, Social Security Administration, Detroit, Michigan. She
received her B.A. degree from Michigan State University (1989), and her J.D.
degree from Catholic University of America Columbus School of Law (1992).
This article was prepared from a paper Ms. Robichaud submitted as part of the
requirements for an L.L.M. degree from Wayne State University, under the
direction of Tammy Lundstrom, M.D., J.D. The views set forth in this article are
the personal views of the author and do not represent the views of the Social
Security Administration. © Sarah Robichaud 2009.
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This paper advocates several additional alternatives to further
improve the process for cases with special conditions. Using HIV
infection as an example of a special condition, this paper
recommends (1) using electronic screening tools to efficiently
identify cases for adjudication at the earliest opportunity; (2) using
specialized medical source statements in combination with Social
Security Administration forms to improve the probability of
accurately assessing individuals with special conditions; and (3)
reviewing cases with special conditions regionally or nationally in
order to focus resources to enhance the assessment of such cases.
These improvements will help adjudicators in the Office of
Disability Adjudication and Review to efficiently handle the backlog
of cases dealing with varied and complex conditions and to more
effectively serve individuals who have filed for disability.
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I. INTRODUCTION
The Social Security Act (Act), as initially enacted, was fairly
limited in scope. From its modest beginnings, the Social Security
program has evolved to become a major aspect of modem life.1 The
Act currently offers two separate types of benefit programs. The
Social Security disability insurance program under Title II of the Act
pays benefits to individuals who have worked long enough and paid
Social Security taxes. Certain family members may also qualify for
benefits under this part of the Act. The supplemental security income
program under Title XVI of the Act pays benefits to disabled adults
and children who have limited income and resources. 2 While Title II
and Title XVI of the Act are critical to many people, until recently,
the way that the Social Security Administration (SSA) processed
medical information to determine disability had not changed in any
fundamental way since the inception of the Act.
Individuals seeking benefits initially apply by submitting
information about their condition and how it affects their ability to
work. In making disability decisions, adjudicators consider objective
medical evidence; other evidence from medical sources, including
opinions; statements by the individual and others about the
impairment and how it affects the individual's functioning;
1. The Social Security Administration paid benefits to about 54.7 million
people in 2007, and about 4.7 million people were awarded benefits in 2007.
SOCIAL SECURITY ADMINISTRATION, FAST FACTS & FIGURES ABOUT SOCIAL
SECURITY, 2008, available at
http://www.ssa.gov/policy/docs/chartbooks/fastfacts/2008/fastfacts08. On April
28, 2009, Sylvester J. Schieber, Chairman of the Social Security Advisory Board,
reported that in Fiscal Year 2008, 41.2 million people were receiving retirement
and survivor benefits and 15.1 million people were receiving disability benefits.
He noted that, in that same fiscal year, the Social Security Administration
processed nearly 4.1 million retirement and survivor claims, 2.3 million initial
disability claims, and 559,000 disability hearings. Oversight Hearing on the
Progress made by the Social Security Administration in Implementing the
American Recovery and Reinvestment Act of 2009: Before the Subcomm. on Social
Security of the Comm. on Ways and Means, 11 th Cong. (2009) (statement of
Sylvester J. Schieber, Chairman, the Social Security Advisory Board), available at
http://www.ssab.gov/documents/Schieber SocialSecuritySubcommitte0409final.pd
f. While benefits are available to adults and children, the focus of this paper is
adult disability under the Act.
2. 42 U.S.C. § 1381 (2006).
information from other sources; and decisions by other governmental
and non-governmental agencies. 3
Individuals are "disabled" under the Act if they are "unable to
engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment that can be expected to
result in death, or that has lasted, or can be expected to last, for a
continuous period of not less than twelve months.",
4
The SSA uses a five-step process to determine if an individual is
disabled within the meaning of the Social Security Act.5 First, an
individual who is working and engaged in substantial gainful activity
is not disabled.6 If an individual is not engaged in substantial gainful
activity the SSA will consider, as the second step in the process, the
medical severity of an individual's physical or mental impairment-or
impairments, and whether the impairment has lasted or is expected to
last for a continuous period of at least twelve months.7 At this
second step of the evaluation process, an individual must have a
"severe impairment" to proceed through the disability evaluation
process. "Severe impairment" is a term of art that is defined in the
regulations; the evidence must establish a medically determinable
impairment that is more than a slight abnormality and that has more
than a minimal effect on the ability to do basic physical or mental
work activities.8  Third, the SSA considers whether the medical
3. 20 C.F.R. § 404.1512 (2009); 20 C.F.R. § 416.912 (2009).
4. 42 U.S.C. § 423(d)(1)(A) (2006).
5. 20 C.F.R. § 404.1520 (2009); 20 C.F.R. § 416.920 (2009).
6. 20 C.F.R. § 404.1520(b); 20 C.F.R. § 416.920(b).
7. 20 C.F.R. § 404.1509 (2009), § 404.1520(a)(4)(ii); 20 C.F.R. § 416.909
(2009), § 416.920(a)(4)(ii).
8. 20 C.F.R. § 404.1520(c); 20 C.F.R. § 404.1508 (2009); 20 C.F.R. §
416.920(c); 20 C.F.R. § 416.908 (2009). To establish the existence of a medically
determinable impairment there must be evidence from an "acceptable medical
source." 20 C.F.R. § 404.1513 (2009); 20 C.F.R. § 416.913 (2009); Titles II and
XVI: Considering Opinions and Other Evidence from Sources Who Are Not
"Acceptable Medical Sources" in Disability Claims; Considering Decisions on
Disability by Other Governmental and Nongovernmental Agencies, Social Security
Ruling 06-3p (2006), available at
http://www.socialsecurity.gov/OP Home/rulings/di/O1/SSR2006-03-di-0 l.html.
Adjudicators determining whether a severe impairment exists must analyze an
individual's diagnosis or diagnoses, the limitations alleged, the limitations
established, and whether the diagnosed impairments significantly limit the ability
of the individual to perform basic work activities. Office of Disability and
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severity of the impairment meets or equals one of the listing of
impairments in the SSA regulations. The listing of impairments
describes impairments for each major body system that are
considered severe enough to prevent an individual from doing
substantial gainful activity.9 If the individual meets the requirements
of a listing-level condition, the individual is found disabled without
further inquiry.' 0 Fourth, if the individual does not meet a listing, the
SSA assesses the residual functional capacity of an individual, and
considers whether an individual can perform past work. An
individual who can perform past work is not disabled." Residual
functional capacity is an administrative assessment of the most an
individual can do despite his or her limitations. 2 Fifth, even if an
individual's impairment does prevent the performance of past
relevant work, if other work exists in the national economy that
accommodates the individual's residual functional capacity and
Adjudication Review, Social Security Administration, Guidelines for Rationale in
Title H and Title XIV Initial Entitlement Decisions, Hearings, Appeals and
Litigation Law Manual, available at http://www.ssa.gov/OPHome/hallex/I-03/I-
3-8-12.html.
9. 20 C.F.R. § 404.1525 (2009); 20 C.F.R. § 416.925 (2009); 20 C.F.R. § 404,
Subpart A, Appendix 1 (2009). In the case of documented HIV infection, as
described in 14.OOE of the preface to the immune system listings, when an
individual meets listing-level requirements for HIV under 14.08 a separate finding
on the duration of the impairment is not required. Social Policy Interpretation
Ruling Titles I and XVI: Evaluation of Human Immunodeficiency Virus Infection,
Social Security Ruling 93-2p (1994), available at
http://www.ssa.gov/OPHome/rulings/di/O1/SSR93-02-di-Ol.html. An impairment
or combination of impairments is medically equal to a listed impairment if the
signs, symptoms, and laboratory findings are "at least equal" in severity and
duration to those of a listed impairment. 20 C.F.R. § 404.1526 (2009); 20 C.F.R. §
416.926 (2009). The listing of impairments contains two parts: Part A for adults
and Part B for children. This article focuses on Part A of the listing of
impairments.
10. 20 C.F.R. § 404.1520(a)(4)(iii); 20 C.F.R. § 416.920(a)(4)(iii).
11. 20 C.F.R. § 404.1520(a)((4)(iv); 20 C.F.R. § 416.920(a)(4)(iv).
12. 20 C.F.R. § 404.1545(a)(1) (2009); 20 C.F.R. § 416.945(a)(1) (2009); see
Policy Interpretation Ruling Titles II and XVI: Assessing Residual Functional
Capacity in Initial Claims, Social Security Ruling 96-8p, available at
http://www.ssa.gov/OPHome/rulings/di/O l/SSR96-08-di-01 .html.
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vocational factors, the individual is not disabled. If the individual
cannot do other work, the SSA will find the individual disabled. 3
If the SSA does not award disability benefits after an initial
determination, an individual may appeal that decision. The Office of
Disability Adjudication and Review (ODAR) administers hearings
and appeals for the SSA. Adjudicators who consider these cases
perform the same five-step analysis to determine whether an
individual is disabled within the meaning of the Act. 4
Over time, the number of cases considered at the ODAR hearing
level has grown. The rising workload and limited resources have
resulted in a significant backlog of cases at the hearing level, with
significant implications for individuals filing for disability, including
a long wait for hearings and disability decisions. The retirement of
the "baby boomer" generation beginning in 2008, and the fact that
people are living longer, will further impact this trend.
There are also ongoing problems with the evaluation of cases
where individuals have special or unusual conditions. Each
individual applying for benefits is unique, and provides a particular
medical history for SSA adjudicators to assess. Adjudicators
evaluating cases with special or unusual conditions must also take
into account symptoms that are not always measurable with objective
medical testing, the fact that the impact of the condition on function
is unique to each individual, and medical advances that may
complicate the correlation of existing objective information with a
functional capacity determination necessary to make a disability
13. 20 C.F.R. § 404.1520(a)(4)(v); 20 C.F.R. § 416.920(a)(4)(v); see also
Walters v. Comm 'r of Soc. Sec., 127 F.3d 525, 529 (6th Cir. 1997) (citing 20 C.F.R.
§ 404.1520).
14. There are nearly 1,200 administrative law judges who hold hearings in
141 hearing offices and over 150 remote hearing locations and issue more than
550,000 decisions a year. The SSA has asked the judges to issue 500 to 700
legally-sufficient decisions each year. Testimony Before the Subcomm. on Social
Security of the H. Comm. on Ways and Means, 110th Cong., (2008) (statement of
Frank A. Cristaudo, C.A.L.J., Office of Disability Adjudication and Review, Social
Security Administration), available at
http://waysandmeans.house.gov/hearings.asp?formmode=printfriendly&id=7384.
In addition to administrative law judges, in 2007, the SSA modified prehearing
procedures to allow attorneys to conduct prehearing proceedings to issue fully
favorable decisions under certain circumstances. Social Security Administration,
Amendment to the Attorney Advisor Program, Interim Final Rule with Request for
Comments, 72 Fed. Reg. 44,763 (Aug. 9, 2007).
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determination. Thus, in the case of an individual with a special or
unusual condition, the information typically available to SSA
adjudicators when making a decision regarding disability might not
adequately ensure an accurate picture of the individual's overall
condition prior to a determination of disability.
These issues present ongoing challenges to SSA adjudicators,
who must provide full and fair hearings in accordance with the Social
Security Act, the Administrative Procedure Act, and the Constitution
of the United States. 5 The SSA is currently updating its business
model with regulatory modifications designed to reduce the backlog
of disability cases before adjudicators at the ODAR hearing level.
These improvements include accelerating the review of cases likely
or certain to be approved, which will improve the process of
disability review for individuals with special conditions while
ensuring a fair hearing process.
With this goal in mind, the SSA recently implemented a category
of conclusively presumptive disabilities called "Compassionate
Allowances" where it is known, by definition, that people with
certain diseases and conditions will be unable to work for at least 12
months.1 6  The conditions on the Compassionate Allowances list
include special conditions with unique characteristics that SSA field
office employees and hearing office adjudicators may not regularly
consider.
Michael J. Astrue, the Commissioner of Social Security, noted
that an accelerated review of cases likely to be approved, including
the review of cases with special conditions, will help the SSA to
reach its goal of reducing the backlog of disability cases at the
hearing level. Commissioner Astrue stated specifically that
"[g]uidance for one rare disease affecting 50,000 Americans will not
be sufficient to improve the process, but if-over time-we can do it
for between 100 to 500 rare diseases, we can make a difference."' 7
15. 5 U.S.C. §§ 554-56 (2006); 42 U.S.C. § 405 (2006).
16. See Social Security Online, Compassionate Allowances,
http://www.socialsecurity.gov/compassionateallowances/. For the initial list of
compassionate allowance conditions, see
http://www.ssa.gov/compassionateallowances/conditions.htm.
17. Compassionate Allowance Outreach Hearing on Rare Diseases: Hearing
Before the Social Security Administration, 110th Cong. (2007) (opening Remarks,
Recognizing this challenge, the SSA is looking ahead to make these
changes for a greater number of conditions, especially with cases
where adjudicators might be uncertain as to what to do. In this way,
the SSA will improve its ability to make a real difference in the lives
of Americans.
The implementation of the Compassionate Allowance initiative is
a strong sign that the SSA is committed to significantly improving
the process of disability review for Americans. This paper evaluates
one condition, human immunodeficiency virus (HIV) infection,
which is not on the initial list of compassionate allowance conditions.
The listing for HIV, under which an individual can be found
disabled, however, was recently updated." Despite updates to the
listing for HIV, individuals with HIV infection face ongoing
problematic delays while awaiting hearings due to the unique and
varied symptoms of their condition, the inconsistent rate of
deterioration from one individual to the next, and the diverse effect of
the symptoms on functional abilities. The condition is, thus, an
excellent example of how SSA adjudicators evaluate a special
condition, and whether, with further updates, the SSA adjudicatory
standards and process can be improved for individuals with special
conditions.
This paper encourages ongoing empathy and creativity in the
handling of cases regarding special conditions that may not be well-
known or regularly seen during routine disability determination
proceedings by SSA adjudicators. Using HIV infection as an
example, the paper considers innovative alternatives to handling
cases with special conditions. The methods that may improve the
way that the SSA handles one condition, in this case HIV infection,
may be applied to other diseases and conditions. This paper suggests
that, if the SSA can further improve the ability of adjudicators to
consider the cases of individuals with HIV infection, such
improvements may affect further positive changes to the SSA
business process and improve the disability determination process for
people with many different types of conditions.
Michael J. Astrue, Comm'r of Social Security), available at
http://www.socialsecurity.gov/compassionateallowances/agendal 204.htm.
18. 20 C.F.R. § 404, Subpart A, Appendix 1, 14.08, available at
http://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-
Adult.htm#14_08.
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II. A BRIEF HISTORY OF THE SOCIAL SECURITY ACT
On June 8, 1934, President Franklin D. Roosevelt announced his
intention to provide a program for Social Security. 19 Following a
committee study and report, President Roosevelt signed the Social
Security Act into law on August 14, 1935. The law created a social
insurance program to pay retired workers, age sixty-five or older, a
continuing income after retirement, and provided unemployment
insurance, old-age assistance, aid to dependent children, and grants to
the states to provide various forms of medical care.
Congress amended the Act in 1939 to pay benefits to the spouse
and minor children of a retired worker and survivor benefits to the
family in the event of the premature death of the worker. President
Truman signed further amendments in 1950 that increased benefits
for beneficiaries. In 1954, President Eisenhower signed amendments
that initiated a disability insurance program; changes in 1956
provided cash benefits to disabled workers who were fifty to sixty-
five years of age and to disabled adult children. Congress further
broadened the program by permitting both disabled workers and their
dependants to qualify for benefits. Changes in the 1960s and 1970s
included the passage of Medicare, which extended health coverage to
beneficiaries; adjustments to benefits to compensate for wage and
price inflation; and the creation of the supplemental security income
program, a needs-based program for the elderly, blind, and disabled.
Changes in 1972 added automatic cost-of-living adjustments based
on the annual increase in consumer prices.
Amendments to the Act in the 1980s included work incentive
provisions and the implementation of periodic reviews of current
disability beneficiaries to certify continuing eligibility for disability.
As a result of financing problems, President Ronald Reagan
appointed the Greenspan Commission to recommend legislative
changes. President Reagan signed amendments in 1983 that included
the partial taxation of Social Security benefits; the coverage of
federal employees; raising the retirement age gradually starting in
2000; and increasing the reserves in the Social Security trust fund.
19. Franklin D. Roosevelt, United States President, Message to Congress
Reviewing the Broad Objective and Accomplishments of the Administration (June
8, 1934), http://www.ssa.gov/history/fdrstmts.html#message 1.
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The SSA became an independent agency in 1995. Thus, the
Commissioner of Social Security reports directly to the President. In
1994 legislation mandated the formation of a permanent, seven-
member, bipartisan Social Security Advisory Board to provide
independent advice and counsel to the President, Congress, and
Commissioner of Social Security on Social Security and
supplemental security income policy.20 The Act was amended in the
1990s to address issues such as the eligibility of noncitizens,
disability benefits to children, work incentives, and beneficiary
safeguards. In 2001, the President's Commission to Strengthen
Social Security-with members appointed by President George W.
Bush-attempted to ensure the future stability of the Social Security
program by recommended options to address long-range financing
shortfalls of the program. By 2006, the Social Security program had
grown to include 49,122,831 disability beneficiaries and 7,235,565
supplemental security income beneficiaries. 2'
Ill. CURRENT DEVELOPMENTS
With advances in science and medicine, the trend away from
physically exertive work, and an aging population, the impact on the
SSA is, and will continue to be, tremendous. Non-traditional
workloads, including immigration enforcement, require a substantial
commitment of resources, and cases regarding complex or special
conditions lead to time-consuming and expensive consultations often
performed by doctors who are unfamiliar with SSA rules and
regulations. Costs are projected to rise steeply between 2010 and
2030 for reasons that include an increase in the number of people
receiving benefits and an anticipated increase in the complexity of
services.22 Ongoing studies show that the payroll tax that finances
20. For more information on the Social Security Advisory Board, see
http://www.ssab.gov/index.html.
21. Social Security: A Brief History, SSA Publication No. 21-059, October
2007, www.socialsecurity.gov. See also David H. Autor & Mark G. Duggan, The
Growth in the Social Security Disability Rolls: A Fiscal Crisis Unfolding, 20 J.
ECON. PERSP., Summer 2006, at 71, 74.
22. Social Security and Medicare Boards of Trustees, Status of the Social
Security and Medicare Programs, A Summary of the 2009 Annual Reports,
http://www.ssa.gov/OACT/TRSUM/index.html.
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Social Security will not raise enough money to cover anticipated
future benefits.2
3
The growing number of cases in the system has resulted in a
current backlog of cases at the ODAR hearing level, where
individuals appeal initial disability determinations before
Administrative Law Judges. 24 In order to ensure continued success
in the basic mission of reducing poverty in old age and insuring
Americans against losses due to disability or the death of a working
spouse or parent, the SSA must continue to address this pressing
issue.
The elimination of the ODAR hearing backlog is a high priority
for the SSA. A year-end report for fiscal year 2008 from the SSA
summarizes progress on its plan to eliminate the hearing backlog and
prevent its recurrence by (1) focusing on compassionate allowances,
(2) improving hearing office procedures, (3) increasing adjudicatory
capacity, and (4) increasing efficiency with automation and improved
business processes. An aggressive effort, during fiscal years 2007
and 2008, towards reaching goals for all of these initiatives resulted
in a significant reduction in the backlog of the aged cases in ODAR
offices nationwide. Notably, changes have included the
implementation of a medical expert screening process, the opening of
a National Hearing Center, the transition to processing files
23. Id.; see also Will Marshall, Social Security and Medicare Reform for the
Twenty-First Century, in UNITING AMERICA: RESTORING THE VITAL CENTER TO
AMERICAN DEMOCRACY, Yale University Press (2005); Autor, supra note 22, at
71-96; The 2007 Annual Report of the Board of Trustees of the Federal Old-Age
and Survivors Insurance and Federal Disability Insurance Trust Funds:
Transmitted to the Committee on Ways and Means, 110th Cong. 23-25 (2002),
available at http://www.ssa.gov/OACT/TR/TR07/tr07.pdf.
24. Erik Eckholm, Disability Cases Last Longer as Backlog Rises, N.Y.
Times, Dec. 10, 2007, at Al; see also Social Security Backlog Grows from Lack of
Cash, The Oregonian, Aug. 4, 2008, at aOl. On January 16, 2008, the Association
of Administrative Law Judges sponsored a roundtable discussion, "Challenges
Facing the Social Security Disability Program." Speakers emphasized the need to
address systemic SSA problems to ensure the sustainability of the program. The
program is available at http://www.aalj.org/09c0l.html.
25. OFFICE OF DISABILITY ADJUDICATION AND REVIEW, SOCIAL SECURITY
ADMINISTRATION, PLAN TO ELIMINATE THE HEARING BACKLOG and PREVENT ITS
RECURRENCE, 1 (Fiscal Year 2008), available at
http://www.ssa.gov/disability/SemiannualReport_FY08.pdf.
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electronically, and the effectuation of temporary service area
realignments and interregional case transfers.
IV. COMPASSIONATE ALLOWANCES
The Compassionate Allowance initiative is a new effort by the
SSA that allows the agency to quickly provide benefits to applicants
with special medical conditions whose conditions are so serious that
they obviously meet the disability listing standards. The initial list of
fifty compassionate allowance conditions, announced in October of
2008,26 allows the SSA to identify diseases and conditions that
invariably qualify for disability under the SSA's listing of
impairments based on minimal, but sufficient, objective medical
information.
The SSA's Listing of Impairments is one of the key elements
used in determining whether or not someone qualifies for disability
benefits. 27  The Listing of Impairments describes, for each major
body system, impairments that are severe enough to prevent an
individual from doing any substantial gainful activity. Most of the
listed impairments are permanent, expected to result in death, or note
a durational requirement. The "criteria in the Listing of Impairments
are applicable to evaluation of claims for disability benefits under the
Social Security disability insurance program" and the supplemental
security program.28
The initial list of compassionate allowance conditions was
developed as a result of information received at public outreach
hearings and from public comment on an Advance Notice of
Proposed Rulemaking, comments received from the SSA and
Disability Determination Service communities, and medical and
26. News Release, Social Security Administration, Social Security Announces
Nationwide Launch of Compassionate Allowances, Process Will Fast Track
Applications For People With Cancers and Rare Diseases (Oct. 27, 2008) available
at http://www.ssa.gov/pressoffice/pr/compassionate-allowances-1008-pr.htm. The
initial list of compassionate allowances is available at
http://www.socialsecurity.gov/compassionateallowances/conditions.htm.
27. 20 C.F.R. § 404.1525, 404.1526, Subpart P, Appendix 1 available at
http://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm.
28. 20 C.F.R. § 404.1525, available at
http://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm.
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scientific experts. 29 The SSA also considered which conditions are
most likely to meet the current definition of disability, and noted that,
after the initiative's initial rollout, the list may expand over time.3 °
The SSA's most recent hearing for Compassionate Allowances
focused on early-onset Alzheimer's disease and related dementias;
other hearings focused on rare diseases, cancers, and traumatic brain
injuries and stroke.3 Early-onset Alzheimer's disease was chosen
for further study because it is a rapidly progressing and debilitating
disease of the brain that affects individuals between fifty and sixty-
five years of age, and with better diagnostic tools and the aging of the
baby boomers, there is an increasing number of individuals
diagnosed with this disease.
SSA Commissioner Michael J. Astrue confirmed, at the hearing
for early-onset Alzheimer's disease, that the top priority of the SSA
is to improve service to disabled Americans by reducing the hearing
backlog and improving accuracy of the decisions and the speed with
which they are issued. He also confirmed that the SSA has been
making steady progress, even with an unprecedented increase in
applications, and that the Compassionate Allowance initiative helps
people with devastating conditions receive decisions as quickly as
possible. Commissioner Astrue noted that the SSA is working to
continually expand the list of compassionate allowances and ensure
that Social Security Administration employees are able to expedite
cases by providing them with the resources to identify conditions;
understand diagnostic testing, coding, disease progression, and
29. The SSA held initial Compassionate Allowance hearings on the following
dates: December 4-5, 2007, for rare diseases; April 7, 2008, for cancers; November
18, 2008, for brain injuries and stroke; and July 29, 2009, for early onset
Alzheimer's disease and related dementia, in order to obtain the public's views
about how to implement Compassionate Allowances for children and adults. For
detailed information on these hearings, see
http://www.socialsecurity.gov/compassionateallowances.
30. For a list of conditions selected for the initiative's rollout, see Social
Security Administration, List of Conditions,
http://www.ssa.gov/compassionateallowances/conditions.htm (last visited Sept. 30,
2009).
31. Announcement of Public Hearing, Compassionate Allowances for Early-
Onset Alzheimer's Disease and Related Dementias, 74 Fed. Reg. 32,817 (July 9,
2009); see also Social Security Administration, Compassionate Allowances
available at http://www.ssa.gov/compassionateallowances/.
29 2
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treatment of the conditions; and consider other medical criteria
necessary to evaluate disability applications. Commissioner Astrue
also noted that the SSA must expand the compassionate allowance
list, shift its focus to a broader category of conditions, and allow
claims based on gradation of severity and symptoms or subsets of
medical conditions that clearly do meet SSA disability standards.
Testimony of experts at these hearings has allowed the SSA to gather
as much information as possible to help identify potential rules to
apply to the most severe cases that meet disability standards, whether
it is in the Compassionate Allowance initiative or some other area in
the disability determination process.
V. HIV INFECTION
HIV infection is an example of a special condition that might
benefit from the efforts of the SSA to improve its processing of cases
at the ODAR hearing level. Under the five-step sequential evaluation
process for disability determination, if an individual with HIV is not
working, the SSA will consider the severity of the individual's
impairment, and whether the medical severity of the individual's
impairment meets or equals the listing for HIV. HIV infection can be
considered a special condition for several reasons. Individuals with
HIV do not need to meet the twelve month durational requirement of
the regulations. 32 The condition has varied effects on individuals,
and individuals react differently to the spectrum of treatment
methods available and that are currently used to treat the condition.
Further, medical technology is resulting in ongoing improvements to
treatment modalities for HIV. Finally, the condition is not often
considered on a daily basis by ODAR adjudicators. Thus, adapting
the way adjudicators consider such cases could allow adjudicators to
32. 20 C.F.R. § 404.1509, § 404.1520(a)(4)(ii)-(iii); 20 C.F.R. § 416.909, §
416.920(a)(4)(ii)-(iii); 20 C.F.R. § 404, Subpart A, Appendix 1. In the case of
documented HIV infection, as described in 14.OOE of the preface to the Immune
System listings, when an individual meets listing-level requirements for HIV under
14.08, a separate finding on the duration of the impairment is not required. Policy
Interpretation Ruling Titles II and XVI: Evaluation of Human Immunodeficiency
Virus Infection, Social Security Ruling 93-2p (1994), available at
http://www.ssa.gov/OP-Home/rulings/di/O l/SSR93-02-di-01 .html.
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more effectively consider whether an individual with HIV meets the
requirements of a listing under the sequential evaluation process.
HIV, or human immunodeficiency virus, is the virus that causes
acquired immunodeficiency syndrome (AIDS). AIDS is the final
stage of HIV infection. The first cases of AIDS were identified in the
United States in 1981, and in 1984 scientists proved that HIV causes
AIDS.33
HIV infects cells in the immune system and the central nervous
system. Once it has found its way into a cell, HIV produces new
copies of itself, which can then go on to infect other cells. Over time,
HIV infection leads to a severe reduction in the number of cells
available to help fight disease. The process usually takes several
years, and infection may go unnoticed, sometimes for years.
HIV infection can generally be broken down into four distinct
stages:
" Primary infection,
" clinically asymptomatic stage,
* symptomatic HIV infection, and
• progression from HIV to AIDS.
Having AIDS means that the virus may have weakened the
immune system to the point to at which an individual's body has
trouble fighting infections.34
If an individual has HIV infection, as the immune system fails,
the individual develops symptoms. Initially, the symptoms may be
mild. However, as the immune system deteriorates, the symptoms
may worsen. Symptomatic HIV infection is mainly caused by the
emergence of opportunistic infections and cancers that the immune
system would normally prevent. These can occur in almost all the
body systems. Symptomatic HIV infection is often characterized by
multi-system disease. Treatment for the specific infection or cancer
is often carried out, but the underlying cause is the action of HIV as it
erodes the immune system. Unless HIV itself can be slowed down,
33. CENTER FOR DISEASE CONTROL AND PREVENTION, U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES, LIVING WITH HIV/AIDS, available at
http://www.cdc.gov/hiv/resources/brochures/livingwithhiv.htm (last visited Sept.
28, 2009).
34. CENTER FOR DISEASE CONTROL AND PREVENTION, U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES, BASIC INFORMATION: HIV/AIDS,
http://www.cdc.gov/hiv/topics/basic/index.htm (last visited Sept. 28, 2009).
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the symptoms of immune suppression will not just continue but will
worsen. As the immune system becomes more and more damaged,
the illnesses that occur become more and more severe, eventually
leading to an AIDS diagnosis.
35
In the United States, someone may be diagnosed with AIDS if
they have certain signs or symptoms defined by the United States
Centers for Disease Control and Prevention (CDC). This includes a
very low count of a certain type of cells in the blood.36 Immune cells
called "CD4 cells" are disabled and killed during a typical course of
infection. Thus, these cells are evaluated by CD4 count. An
uninfected person usually has 800 to 1200 CD4 T cells per cubic
millimeter (mm 3) of blood. HIV infection typically involves a
decrease in the number of CD4 cells, with a resulting decrease in the
effectiveness of the immune system. Antiretroviral therapy is often
recommended for individuals with a history of AIDS-defining illness
or severe symptoms of HIV, regardless of CD4 cell count. The CDC
regularly publishes treatment guidelines for the use of antiretroviral
therapy for individuals infected with HIV. 37  However, when an
individual's CD4 T cell count falls below 200, the individual can
become particularly vulnerable to opportunistic infections and
cancers that typify AIDS. It is possible for someone to be very ill
with HIV but not have an AIDS diagnosis. In comparison, at present
in the United Kingdom, an AIDS diagnosis is confirmed if a person
with HIV develops one or more of a specific number of severe
opportunistic infections or cancers.
38
35. Avert.org, The Different Stages of H1V Infection,
http://www.avert.org/stages-hiv-aids.htm (last visited Sept. 29, 2009); NATIONAL
INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, DEPARTMENT OF HEALTH AND
HUMAN SERVICES, How HIV CAUSES AIDS,
http://www3.niaid.nih.gov/topics/HIVAIDS/Understanding/How+HV+Causes+AI
DS/ (last visited Sept. 30, 2009).
36. CENTER FOR DISEASE CONTROL AND PREVENTION, U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES, BASIC INFORMATION: HIV/AIDS
http://www.cdc.gov/hiv/topics/basic/index.htm (last visited Sept. 28, 2009).
37. AIDS Info, U.S. Department of Health and Human Services,
http://www.aidsinfo.nih.gov/Guidelines/ (last visited Sept. 30, 2009).
38. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,
DEPARTMENT OF HEALTH AND HUMAN SERVICES, How HIV CAUSES AIDS,
http://www3.niaid.nih.gov/topics/HIVAIDS/Understanding/How+HIV+Causes+AI
DS/ (last visited Sept. 30, 2009).
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The CDC estimates that about 1,106,400 people are living with
HIV in the United States, indicating a prevalence rate of 447.8 cases
per 100,000 persons. The CDC further estimates that of those
individuals, approximately one in five, or twenty-one percent, do not
know they are infected. Men who have sex with men of all races,
African Americans, and Hispanics/Latinos are disproportionately
affected by HIV. 39 Today, more people are living with HIV because
of better treatments and because, while the number of new HIV
infections per year has remained stable in recent years, more people
become infected with the disease than die from the disease each year.
Data shows that seventy percent of individuals living with HIV in the
United States are between the ages of twenty-five and forty-nine.4 °
Jeffrey P. Nadler, M.D., Acting Director of the Therapeutics
Research Program, Division of AIDS, National Institute of Allergy
and Infectious Diseases (NIAID), reported at a September 10, 2008
conference on HIV sponsored by the SSA that medical advances
have substantially improved the treatment of opportunistic infections
that previously limited the survival rate for people with HIV. As a
result, statistics show more people living with HIV but a decrease in
the number of AIDS cases and deaths in the United States between
1985 and 2006. 41 Dr. Nadler suggested that ongoing disease issues
related to HIV include viral resistance; demographic changes that
increasingly include infected women; and the treatment of HIV in an
aging population with secondary physical and mental conditions such
39. Liz Highleyman, CDC Updates Estimates of HIV Prevalence in the
United States, Oct. 7, 2008,
http://www.hivandhepatitis.com/recent/2008/100708_a.html; CENTER FOR DISEASE
CONTROL AND PREVENTION, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES,
QUESTIONS AND ANSWERS: HIV PREVALENCE ESTIMATES-UNITED STATES, 2006,
http://www.cdc.gov/hiv/topics/surveillance/resources/qa/prevalence.htm. For
example, the CDC reports that black men have an HIV prevalence rate of 2,388 per
100,000 people, which is six times as high as the rate for white men (395 per
100,000) and black women have an HJV prevalence rate of 1,122 per 100,000
people, which is 18 times as high as the rate for white women (63 per 100,000).
40. CENTER FOR DISEASE CONTROL AND PREVENTION, U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES, QUESTIONS AND ANSWERS: HIV PREVALENCE
ESTIMATES-UNITED STATES, 2006,
http://www.cdc.gov/hiv/topics/surveillance/resources/qa/prevalence.htm.
41. CENTER FOR DISEASE CONTROL AND PREVENTION, U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES, HIV/AIDS STATISTICS AND SURVEILLANCE,
http://cdc.gov/hiv/topics/surveillance/index.htm (last visited Sept. 23, 2009).
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as diabetes, neuropathy, chronic hepatitis C, subtle cognitive
impairment, and depression.42
The discovery and development of new therapeutic strategies
against HIV infection is a high priority for the NIAID. Research
supported by NIAID has already greatly advanced understanding of
HIV and how it causes disease. This knowledge provides the
foundation for NIAID's HIV/AIDS research effort and continues to
support studies designed to further extend and improve the quality of
life of those infected with HIV.43
The Food and Drug Administration has approved thirty
antiretroviral drugs to treat people with HIV. These drugs fall into
four major classes: Reverse transcriptase (RT) inhibitors, protease
inhibitors, entry and fusion inhibitors, and integrase inhibitors. RT
inhibitors interfere with the critical step during the HIV life cycle
known as reverse transcription. During this step, RT, an HIV
enzyme, converts HIV RNA to HIV DNA to block HIV from
replicating in a cell. Protease inhibitors interfere with the protease
enzyme that HIV uses to produce infectious viral particles. Entry and
fusion inhibitors interfere with the virus' ability to fuse with the
cellular membrane, thereby blocking entry into the host cell.
Integrase inhibitors block integrase, the enzyme HIV uses to integrate
genetic material of the virus into its target host cell. There are also
multidrug combinations that incorporate drugs from more than one
class into a single product. The drugs do not cure HIV infection or
AIDS but can suppress the virus. Thus, individuals with HIV must
continuously take antiretroviral drugs.44
Doctors recommend that people infected with HIV take a
combination of antiretroviral drugs known as highly active
42. A recent study notes that as an individual's CD4 cells reproduce over
many years, they become less functional, and suggests that the premature aging of
CD4 cells is linked to faster disease progression in HIV-positive individuals.
Weiwei Cao et al., Premature Aging of T cells Is Associated With Faster HIV-1
Disease Progression, 50 J. Acquired Immune Deficiency Syndrome, Feb. 2009, at
137-47.
43. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,
DEPARTMENT OF HEALTH AND HUMAN SERVICES, TREATMENT OF HIV INFECTION,
(2007), http://www.niaid.nih.gov/factsheets/treat-hiv.htm.
44. Id.
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antiretroviral therapy, or HAART.4 5  This is because, as HIV
reproduces itself, variants of the virus emerge, including some that
are resistant to antiretroviral drugs. Combining drugs from at least
two different classes of antiretroviral drugs can effectively suppress
the virus when used properly. This can reduce an individual's viral
load (the measure of the quantity of HIV virus in the blood) to very
low levels and can delay the progression of HIV for prolonged
periods. Developed by NIAID-supported researchers, HAART has
revolutionized how people infected with HIV are treated. HAART
works by suppressing the virus and decreasing the rate of
opportunistic infections. While people infected with HIV have
impaired immune systems that are susceptible to opportunistic
infections, therapies such as HAART often allow the immune system
to recover and protect an individual from other infections. Thus,
antiretroviral drugs provide a way for the immune system to remain
effective, thereby improving the quality and length of life for people
with HIV.46
Judith A. Aberg, M.D., Directory of Virology, Bellevue Hospital
Center, and Associate Professor of Medicine, New York University
School of Medicine, spoke at the conference on HIV sponsored by
the SSA on September 10, 2008. Dr. Aberg confirmed that while
there have been remarkable advances in HIV treatment, only fifty to
sixty percent of people respond to antiretroviral therapy, many people
remain undiagnosed until late in the disease process, and nearly fifty
percent of people with HIV/AIDS in need of antiretroviral treatment
are not receiving therapy.
Clearly, late diagnosis and treatment makes a difference. Data
indicates that individuals diagnosed with AIDS at the time of initial
presentation were fifty-five percent more likely to die of an HIV-
related cause, and that more than fifty percent of deaths occurred
45. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,
DEPARTMENT OF HEALTH AND HUMAN SERVICES, GUIDELINES FOR THE USE OF
ANTIRETROVIRAL AGENTS IN HIV- I-INFECTED ADULTS AND ADOLESCENTS (2008),
available at http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf.
46. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,
DEPARTMENT OF HEALTH AND HUMAN SERVICES, TREATMENT OF HIV INFECTION
(2007), available at http://www.niaid.nih.gov/factsheets/treat-hiv.htm.
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within four months of a diagnosis. 4  Dr. Aberg confirmed that
people diagnosed late are more difficult to treat, and are less likely to
fully benefit from antiretroviral treatment.
Effective suppression of HIV requires strict adherence to potent
medications with serious side effects. While rates of adverse drug
effects that limit treatment have been declining with the introduction
of newer antiretroviral regimens, adverse affects from antiretroviral
drugs are common, and may be a reason for switching or
discontinuing therapy. Many individuals are resistant to at least one
drug. Also, a pathogen-specific inflammatory response that may be
triggered by initiation, re-initiation, or a change to a more active
antiretroviral therapy, called Immune Reconstitution Inflammatory
Syndrome (IRIS), may severely complicate treatment.48
Medical advances have substantially improved the prognosis of
many, but not all, opportunistic infections. Opportunistic infections
may still result in persistent illness or death unless there is significant
immune improvement, such as is often seen in HIV with HAART
(although this is not necessarily a rapid improvement). Further, other
complications to treatment abound. Studies suggest drug resistance
of six to eighteen percent in people who are new to antiretroviral
treatment. Further, incomplete adherence can result from complex
regimens. Substance abuse, drug side effects, interactions between
psychotropic and antiretroviral agents, toxicity, co-infection with
other conditions, and affective disorders may further adversely affect
compliance. Access to adequate treatment and education may also
affect treatment response.49
Cases in which individuals have HIV infection present SSA
adjudicators with special challenges. Records for such cases may
47. Judith E. Sackoff et al., Causes of Death among Persons with AIDS in the
Era of Highly Active Antiretroviral Therapy: New York City, 145 ANNALS OF
INT'L MED., September 2006, at 397-406.
48. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,
DEPARTMENT OF HEALTH AND HUMAN SERVICES, GUIDELINES FOR THE USE OF
ANTIRETROVIRAL AGENTS IN HIV-1-INFECTED ADULTS AND ADOLESCENTS 95
(2008), available at
http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf.
49. Id.; Marshall Forstein et al., American Psychiatric Association, Guideline
Watch: Practice Guidelines for the Treatment of Patients with HIV/AIDS, at 3
http://www.psychiatryonline.com/content.aspx?aID=44070 (last visited Oct. 5,
2009).
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contain a complex combination of constantly-evolving drug
treatment modalities that have diverse effects on different
individuals. The records evidence a range of responses to treatment
based on compliance with treatment, socioeconomic factors, and
mental health issues. The condition is not regularly considered by
ODAR adjudicators. Implementing methods to improve the way that
adjudicators handle cases where HIV is a severe impairment would
improve the processing of those cases at the hearing level, and allow
adjudicators to more accurately determine whether an individual with
HIV meets the requirements of a listing under the sequential
evaluation process. Such methods, in turn, might be used and have
positive implications for other cases that contain special conditions.
VI. SOCIAL SECURITY ADMINISTRATION REGULATION OF HIV
INFECTION
Under the five-step Social Security disability evaluation process,
if an individual is not working and has a severe impairment, a SSA
adjudicator then considers whether the medical severity of the
individual's impairment or impairments meets or equals one of the
listing of impairments.5" The listing of impairments that adjudicators
use to define adult disability in the sequential evaluation process
includes, in listing 14.00, immune system disorders that cover a wide
variety of conditions, including systemic lupus erythematosus,
systemic vasculitis, systemic sclerosis and scleroderma, polymyositis
or dermatomyositis, undifferentiated connective tissue disorder,
immunoglobulin deficiency syndromes, inflammatory arthritis, and
HIV infection. 5' Listing 14.08 deals specifically with HIV infection.
HIV infection was not included in the recent initial list of
Compassionate Allowances. However this author suggests that HIV
50. 20 C.F.R. § 404.1509, § 404.1520(a)(4)(ii)-(iii); 20 C.F.R. § 416.909, §
416.920(a)(4)(ii)-(iii); 20 C.F.R. § 404, Subpart A, Appendix 1. In the case of
documented HIV infection, as described in 14.OOE of the preface to the Immune
System listings, when an individual meets listing-level requirements for HIV under
14.08, a separate finding on the duration of the impairment is not required. Policy
Interpretation Ruling Titles II and XVI: Evaluation of Human Immunodeficiency
Virus Infection, Social Security Ruling 93-2p, available at
http://www.ssa.gov/OPHome/rulings/di/Ol/SSR93-02-di-01 .html.
51. 20 C.F.R. § 404, Subpart A, Appendix 1.
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is a special condition and that individuals with HIV infection present
adjudicators with a wide array of challenges. Thus, listing 14.08 is a
good starting point for studying ways that the SSA may consider
additional methods to improve the process by which adjudicators
consider cases with special conditions that they may not handle on a
regular basis.
The SSA recently updated how it handles listing-level immune
system disorders. On March 18, 2008, the SSA published Final
Rules regarding revised medical criteria for evaluating immune
system disorders.5 2 These changes became effective on June 16,
2008. The Social Security Administration specifically noted, in
March of 2008, that after considering the advances in treatment and
resulting increases in longevity, the agency did not initially "believe
that there had been sufficient progress in the treatment and control of
HIV infection to warrant any change" to listing 14.08 for HIV. As a
result of public comments, however, the SSA determined that
changes might be appropriate, and invited further comments and
suggestions on how to update and revise the listings for HIV through
an Advance Notice of Proposed Rulemaking.5 3
Currently, an individual with HIV infection may be found
disabled under listing 14.08. Documentation of HIV infection must
be provided, and must include "laboratory evidence" or "other
generally acceptable methods consistent with the prevailing state of
medical knowledge and clinical practice." 54 Laboratory tests used to
satisfy the listing standard of documentation include HIV antibody
tests, positive "viral load" tests, HIV DNA detection by polymerase
chain reaction, a specimen that contains HIV antigen, a positive viral
culture for HIV from peripheral blood mononuclear cells, and other
tests "that are highly specific for detection of HIV and that are
consistent with the prevailing state of medical knowledge."55 Other
acceptable documentation of HIV provided without the definitive
laboratory evidence must also be consistent with the prevailing state
of medical knowledge and clinical practice, and must be consistent
52. Revised Medical Criteria for Evaluating Immune System Disorders, Final
Rules, 73 Fed. Reg. 14,409 (March 18, 2008).
53. 73 Fed. Reg. 14,583.
54. 20 C.F.R. § 404, Subpart A, Appendix 1, 14.00F(1)(a)-(b).
55. Id. at 14.00F(l)(a)(i)-(vi).
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with other evidence in the case record. 56 To meet listing-level
requirements for HIV, the medical evidence must also include
documentation of the manifestations of HIV.57
Listing 14.08 for HIV infections requires documentation of the
condition and one of the following: bacterial infections; fungal
infections; protozoan or helminthic infections; viral infections;
malignant neoplasms; conditions of the skin or mucous membranes;
HIV encephalopathy; HIV wasting syndrome; diarrhea; other
infections that are either resistant to treatment or that require
hospitalization or intravenous treatment three or more times in a
twelve-month period; or "repeated" manifestations of HIV infections
that result in significant, documented symptoms or signs (for
example, severe fatigue, fever, malaise, involuntary weight loss, pain,
night sweats, nausea, vomiting, headaches, or insomnia) and one of
the following at the "marked" level: limitation of activities of daily
living, limitation in maintaining social functioning, or limitation in
completing tasks in a timely manner due to deficiencies in
concentration, persistence, or pace.5 8
The terms "repeated" and "marked" are defined in the
regulations. The term "marked" means "more than moderate but less
than extreme" and may arise if "several activities of function are
impaired, or even when only one is impaired, as long as the degree of
limitation is such as to interfere seriously with your ability to
function independently, appropriately, effectively, and on a sustained
basis."5 9 The term "repeated" means that the manifestations occur on
an average of three times a year, or once every 4 months, each lasting
2 weeks or more; or the manifestations do not last for 2 weeks but
occur substantially more frequently than three times in a year or once
every 4 months; or they occur less frequently than an average of three
times a year or once every 4 months but last substantially longer than
56. Id. at 14.00F(l)(b). The documentation requirement for HIV confirms
that a decreased CD4 count increases the susceptibility to opportunistic infection
but that such a reduced CD4 count, while useful as supportive evidence along with
clinical findings where there is not a definitive diagnosis of an opportunistic
infection, does not alone establish a definitive diagnosis of HIV or document the
severity of functional limitations of HIV. Id. at 14.00F(2).
57. Id. at 14.OOF(3)-(5).
58. 20 C.F.R. § 404, Appendix 1 to Subpart P, 14.08 A-K.
59. 20 C.F.R. § 404, Appendix I to Subpart P, 12.00.
2 weeks. Your impairment will satisfy this criterion regardless of
whether you have the same kind of manifestation repeatedly, all
different manifestations, or any other combination of manifestations;
for example, two of the same kind of manifestation and a different
one. You must have the required number of manifestations with the
frequency and duration required in this section. Also, the
manifestations must occur within the period covered by your claim.60
As a result of comments and suggestions received in response to
the Advance Notice of Proposed Rulemaking, the SSA hosted, on
September 10, 2008, a one-day conference, titled "HIV Infection in
the Disability Programs," to receive expert opinions regarding
evaluation of HIV by the SSA and how the overall process can be
improved.
The conference included presentations by physicians, hospital
directors, and legal aid and education groups. Conference presenters
spoke about the history of HIV infection, listing-level requirements
for HIV infection, ideas for the improvement of regulations related to
HIV disability, the relation of HIV infection and mental health, and
HIV infection in children and adolescents. Conference participants
confirmed how the impact of HIV on functioning is unique to each
patient, and remarked on how the conference was a positive step
toward improving the disability process for individuals with HIV.
VII. PROCESS IMPROVEMENT FOR SPECIAL CONDITIONS
The SSA's disability determination process is logical for many
frequently handled, well-known, and well-understood conditions.
However, there are a significant number of cases that consider
special or other conditions that are not as well-known or regularly
considered by SSA ODAR adjudicators. For example, in a statement
at a compassionate allowance outreach hearing on rare diseases in
December of 2007, Stephen Groft, Pharm. D., Director of the
National Institute of Heath Office of Rare Disease, confirmed that
with approximately 7000 inherited or acquired rare diseases affecting
between 25 to 30 million people in the United States, there is no one
predictable pattern of progression of the disorders that may
60. 20 C.F.R. § 404, Appendix 1 to Subpart P, 14.00(I)(3).
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eventually result in mental or physical disability.61  As a result,
individuals with such special conditions who are seeking disability
may experience delay and unwarranted denials.
Further challenges include instances where not all of the
conditions that an individual is experiencing are identified at the
onset of the application process; the lack of a standard form relating
to a specific special condition to carefully document symptoms,
related conditions, and limitations; physicians who are not specialists
with specific knowledge of a special condition; lack of treatment due
to socioeconomic and other factors; and doctors and other care
providers who might not understand the SSA disability standard and
who do not know what information to submit for the adequate
analysis of a special condition.
In this section, the author recommends changes that the SSA
could implement for people with special conditions, which would
result in SSA ODAR adjudicators giving more focused attention to
claims from individuals who are unresponsive to treatment, suffer
from the combined impact of several conditions, or have special
conditions that are not commonly handled on a regular basis by SSA
adjudicators. There are several alternatives that SSA adjudicators
could use to increase the efficiency with which such cases are
handled. They include using electronic tools to sort cases by
diagnosis code or other relevant factors such as age; using specialized
medical source statements in combination with SSA forms for special
conditions to improve the probability of accurately assessing
individuals with special conditions; allowing a cadre of attorneys or
judges with special training to screen cases with special conditions;
and continually considering ongoing advances in technology and
treatment as they relate to special conditions to ensure the ongoing
accurate screening and review of these cases.
61. Compassionate Allowance Outreach Hearing on Rare Diseases: Hearing
Before the Social Security Administration, 10th Cong. (2007) (statement of
Stephen Groft, Pharm.D., Director, NIH Office of Rare Diseases), available at
http://www.socialsecurity.gov/compassionatealiowances/agenda 1 204.htm.
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A. Sorting by Diagnosis Code: Chicago Adjudication Screening Tool
Pilot Program
SSA adjudicators could dramatically improve workload
management through the use of sophisticated electronic screening
tools. While the SSA is in the early stages of analyzing the
characteristics of individuals who request hearings before ODAR
adjudicators, the use of such technology during the prehearing review
process could significantly improve case management at the hearing
level. Use of such technology could streamline the prehearing
review process, ensure accountability by requiring a record of the
review, and simplify the hearing process when the record contains a
prehearing review report with a summary of the record and reasons
why the case was not decided prior to a hearing.
Regular processing of cases at the ODAR hearing level includes
hearings. Due to the increase in requests for hearings, the high
number of pending cases at the hearing level, and the projected
increase in requests for hearings, in 2007, the SSA modified
prehearing proceeding procedures. In undertaking this change, the
SSA hoped to address the increased workload at the hearing level by
deciding cases in a more efficient manner and processing cases
without infringing on the right of an individual to a hearing. To do
this, the agency published a rule that allows attorney advisors to
conduct prehearing proceedings if "new and material evidence is
submitted, there is an indication that additional evidence is available,
there is a change in the law or regulations, or there is an error in the
file or some other indication that a wholly favorable decision could
be issued.,
62
The SSA intended the amendment to the attorney advisor
program to significantly reduce the high number of cases pending at
the hearing level.63 In September of 2008, Judge Ron Bernoski,
62. Amendment to the Attorney Advisor Program, 72 Fed. Reg. 44,763 (Aug.
9, 2007) (interim final rule with request for comments). Senior attorney advisors,
hearing office directors, supervisory attorney advisors, and attorneys in the regional
offices at the GS-13 level and above were authorized to issue fully favorable
decisions under the interim final rule.
63. From November 1, 2007, through June 27, 2008, attorney adjudicators
issued 17,254 decisions. Initiatives to Eliminate the Social Security Administration
Hearing Backlog Status as of June 27, 2008, available at
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President of the Association of Administrative Law Judges, noted
support for this measure, noting specifically that such prehearing
review by an attorney may narrow the issues of a case, lead to a
settlement prior to hearing, or result in the resolution of the case prior
to the case going to an administrative law judge, thus positively
impacting the judge's docket and the disability case backlog.64 As
part of the SSA's ongoing effort to reduce the number of claims
pending at the hearing level and issue timely, legally sufficient
decisions, on July 13, 2009, the SSA extended, for two years, the rule
authorizing attorney advisors to conduct certain prehearing
procedures and issue fully favorable decisions. 65
To determine if fully favorable decisions can be rendered,
adjudicators, including some attorney advisors, can screen cases that
are referred to them from representatives, claimants, or staff as
potentially fully favorable decisions. Adjudicators also receive cases
to screen after case intake into a hearing office. The cases are chosen
for screening based on specified profiles that may include the age,
education, vocational history, and condition of the individual filing a
request for hearing. Where enough evidence exists to support a
finding of disability, an adjudicator issues a favorable decision
without waiting for a hearing, thus saving the individual, as well as
the SSA, the time and money required to complete a hearing process.
To further improve the speed and quality of the ODAR disability
hearing process, under the leadership of Regional Chief
Administrative Law Judge, Paul C. Lillios, the Chicago Adjudication
Screening Tool (CAST) was developed to efficiently identify cases
for potential adjudication at the earliest opportunity. Data available
through CAST included commonly implemented adjudicator
screening criteria, and allowed for adjudicators to run searches based
on an individual's age, initial determination date, and many other
http://www.ssa.gov/legislation/BacklogStatus071808.pdf. In February of 2009, the
Office of the Chief Administrative Law Judge issued a new attorney adjudicator
worksheet for attorney adjudicators to complete when unable to issue fully
favorable decisions, in order to reduce subsequent time screening cases.
64. Testimony Before the Subcomm. on Social Security of the H. Comm. on
Ways and Means, 110th Cong., (2008) (statement of J. Ron Bernoski, President,
Association of Administrative Law Judges),, available at
http://waysandmeans.house.gov/hearings.asp?formmode=view&id=7390.
65. Attorney Advisor Sunset Date Extension, 74 Fed. Reg. 33,3327 (July 13,
2009).
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factors that can be tailored to workload needs. The tool also was
designed to allow adjudicators to screen cases based on diagnosis
code. Diagnosis codes identify and classify diseases and conditions
numerically.
CAST was designed to provide the most comprehensive
information available about cases in the SSA today. The tool
allowed ODAR adjudicators to access critical information, regardless
of their proficiency with spreadsheet use, to easily find relevant, up-
to-date, and accurate information. The data was in an easily
understandable format that was simple to tailor to specific needs.
This tool enhanced the ability of adjudicators, through a standardized
practice, to determine prior to a hearing if a favorable disability
determination could be rendered based on specific profiles and
screening criteria.
In a study in the Detroit ODAR in December of 2008, CAST data
revealed nineteen cases where HIV infection was the primary
diagnosis code. Of those cases, four, or twenty-one percent, were
found eligible for payment. Two individuals were found to meet
listing 14.08 and two individuals were found disabled at step five of
the sequential evaluation process after being found unable to do other
work.
The CAST study in the Detroit ODAR was brief but indicates
that future use of such an electronic screening tool could benefit
individuals with special conditions who have filed for disability by
allowing for screening for possible fully favorable decisions by
diagnosis code. In the two cases in which individuals were found
disabled at step five of the evaluation process as unable to do other
work, one individual was an older individual who had lost about
twenty-five percent of his body mass and another had complications
related to HIV infection and postpolio sequelae. In the two cases in
which individuals were found to meet the listing requirements, both
individuals met the requirements of listing 14.08 due to marked
limitation in activities of daily living or the ability to maintain
concentration, persistence, or pace due to symptoms including
fatigue, diarrhea, and gastrointestinal problems. The allegations of
the individuals in these cases were supported by treatment notes from
treating sources and were further supported, in one case, by
accompanying family member confirmation of ongoing problems.
The results of the study of case screening by diagnosis code using
CAST are consistent with results of the SSA Chicago Office of
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Quality Performance (OQP) screening unit. Since March 31, 2008,
that office has been screening ODAR cases in order to identify
possible fully favorable decisions that do not require hearings. As of
mid- September 2008, the screening unit had reviewed over 880
cases. Of those cases, 198, or 22.5%, resulted in fully favorable
decisions.66
As a result of its success on a regional level, CAST was recently
approved for use as a national disability adjudication reporting tool.
These tools, maintained by the SSA's Division of Information
Technology and Integration, contain data extracted daily from
hearings and appeals data and case processing management system
data. Adjudicators at the hearing level can now use the Division of
Information Technology and Integration's screening tool to screen
for cases in a specific hearing office based on hearing request date,
age of claimant, diagnosis code, education, alleged onset date of
disability, and other factors. The Detroit CAST study confirms that it
is effective to search by diagnosis code for individuals with special
conditions in order to prevent individuals with these chronic
conditions from waiting unnecessarily for a hearing.
B. Using Specialized Medical Source Statements for Prehearing
Review of Special Conditions
Adjudicators may consider medical opinions when making
disability determinations.67 Medical source statements may contain
medical opinions submitted by acceptable medical sources. 68 These
statements, based on a source's treatment records and examinations
of an individual, are opinions about an individual's physical and/or
mental abilities to perform work-related activities on a sustained
basis. A medical source statement of the ability of an individual to
do physical work-related activities requests an opinion regarding an
individual's ability to lift/carry, sit/stand/walk, use the hands and
feet, climb, balance, stoop, kneel, crouch, crawl, hear, see, and work
66. State of the Region-Chicago Fiscal Year 2008, Social Security
Administration, Office of Disability Adjudication and Review, Nov. 2008, p. 4.
67. 20 C.F.R. § 404.1527(a)(2); 20 C.F.R. § 416.927(a)(2).
68. Acceptable medical sources are licensed physicians, licensed or certified
psychologists, licensed optometrists, licensed podiatrists, and qualified speech-
language pathologists. 20 C.F.R. § 404.1513(a); 20 C.F.R. § 416.913(a).
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around certain environmental conditions. 69 Administrative findings
regarding whether an individual is disabled or unable to work are
reserved to the Commissioner. However, adjudicators must evaluate
all the evidence in the case record, including statements by the
individual and others about the impairment and how it affects the
individual's functioning, and must weigh medical source statements
to determine the extent to which the opinion is supported by the
record.v
Generally, opinions from treating sources receive more weight
due to the ability of such a source to provide a longitudinal record
and comprehensive perspective on an individual's medical condition.
Further, treating source opinions may be given controlling weight if
the opinion is well supported and not inconsistent with other
evidence in the record.71  Thus a medical statement from such a
source can be quite helpful to an adjudicator, especially in the case of
an individual with a special condition.
In the current disability process, SSA adjudicators also consider
SSA disability reports and function reports when making disability
determinations. These agency forms are used to request information
from an individual about his or her illnesses, injuries, and conditions
and how they affect the individual; work history; medical records;
medications; tests; education; proficiency with the English language;
and daily activities. 72 Adjudicators might also be asked to consider
69. An example of a medical source statement of an individual's ability to do
physical work-related activities can be found in Social Security Administration
Form HA-I151-BK, available at http://www.dshs.wa.gov/pdf/ccs/RFQ0735-
256K.pdf.
70. 20 C.F.R. § 404.1512 and 1527(a), (b), (d); 20 C.F.R. § 416.912 and
927(a), (b), (d); Policy Interpretation Ruling Titles II and XVI: Medical Source
Opinions on Issues Reserved to the Commissioner Social Security Ruling 96-5p
(1996), http://www.ssa.gov/OPHome/rulings/di/Ol/SSR96-05-di-O1 .html; 20
C.F.R. § 404.1527(d)(2); 20 C.F.R. § 416.927(d)(2).
71. 20 C.F.R. § 1527(d)(2); 20 C.F.R. § 416.927(d)(2).
72. See Disability Report - Adult, Form SSA-3368-BK, available at
http://www.ssa.gov/online/ssa-3368.pdf; Function Report - Adult, Form SSA-
3373-BK, available at http://www.disabilitydoc.com/storage/ssa3373-
Function%20Report-Adult.pdf. The SSA-3373-BK asks questions about where an
individual lives; and whether the individual cares for others, cares for pets, requires
assistance for caring for others, has personal care problems, needs special
reminders, can prepare meals and do house and yard work, drives, uses public
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special forms when they consider a case where an individual is
experiencing conditions such as asthma or epilepsy. These forms
request specific, detailed information from an individual about his or
her condition, treatment, and medications to help adjudicators
determine the severity and limiting effects of the condition. The
current medical report form used by the SSA for individuals with
allegations of HIV infection requests information on how the HIV
infection was diagnosed, opportunistic and indicator diseases, and
other manifestations of HIV infection.73
The generalized medical source statement, disability report, and
function report forms used by the SSA today may miss some
problems and symptoms related to HIV infection, or other special
conditions. Specialized medical source statements that improve the
probability of accurately assessing individuals with special
conditions, used alone or in combination with the SSA's medical
report on HIV, will improve the prehearing review process for cases
in which HIV infection is a condition. The wider dissemination and
use of a specialized medical source statement and the SSA's medical
report on HIV will further improve this process.
The SSA may consider the use of a specialized medical source
statement that is based on more detailed criteria for measuring quality
of life and functional abilities to further improve its adjudicatory
process. Such criteria have proved useful in oncology, where
performance status measures help to quantify a cancer patient's
general well being. These measures are scales of objective criteria
for measuring quality of life in individuals with incapacitating
disease. Quality of life is the degree to which a person is able to
function at a usual level of activity without or with minimal
compromise of routine activities. With cancer patients the
measurement helps to determine whether a person can receive
chemotherapy, if the adjustment of doses of medication is necessary,
and to improve quality of life. The most generally-used scoring
systems are the Karnofsky score and the Zubrod score. The Zubrod
score is used in World Health Organization (WHO) publications.
transportation, shops, handles money, has hobbies and interests, and participates in
social activities.
73. Medical Report of Adult with Allegation of Human Immunodeficiency
Virus (HIV) Infection, Form SSA-4814-F5, available at
http://www.legisit.com/forms/SSA-4815-F5.pdf.
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The Karnofsky score runs from 100 to 0. In this system, 100 is
"perfect" health and 0 is death. It is named after Dr. David A.
Karnofsky, who described the scale with Dr. Joseph H. Burchenal in
1949:74
* 100 - Normal, no complaints, no signs of disease.
* 90 - Capable of normal activity, minor signs or symptoms of
disease.
* 80 - Normal activity with effort; some signs or symptoms of
disease.
* 70 - Cares for self; unable to carry on normal activity or to
do active work.
* 60 - Requires occasional assistance but is able to care for
most needs.
* 50 - Requires considerable assistance and frequent medical
care.
* 40 - Disabled; requires special care and assistance.
* 30 - Severely disabled; hospitalization is indicated but death
not imminent.
* 20 - Very sick; hospitalization necessary; active supportive
treatment necessary.
* 10 - Moribund; fatal processes progressing rapidly.
* 0 - Dead.
At 100, a person is able to carry out normal activity and can
work, and needs no special care. At 70, a person is unable to work,
but is able to live at home, care for most personal needs, and requires
a varying degree of assistance. At 40, a person is unable to care for
himself, and requires the equivalent of institutional or hospital care.
The Zubrod score, named after C. Gordon Zubrod, and also
called the WHO or Eastern Cooperative Oncology Group (ECOG)
score, runs from 0 to 5, with 0 denoting perfect health and 5 death: 75
S0 - Asymptomatic (fully active, able to carry on all
predisease activities without restriction).
74. D.A. Karnofsky & J.H. Burchenal, The Clinical Evaluation of
Chemotherapeutic Agents in Cancer in EVALUATION OF CHEMOTHERAPEUTIC
AGENTS, 196 (C.M. MacLeod ed.) (1949), available at
http://www.acsu.buffalo.edu/-drstall/kamofskyoriginal.html.
75. M.M. Oken et al., Toxicity and response criteria of the Eastern
Cooperative Oncology Group, 5 AM. J. CLN. ONCOL. 6, 649-55 (1982).
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* 1 - Symptomatic but completely ambulatory (restricted in
physically strenuous activity but ambulatory and able to
carry out work of a light or sedentary nature. For example,
light housework, office work).
* 2 - Symptomatic, <50% in bed during the day (ambulatory
and capable of all self care but unable to carry out any work
activities. Up and about more than 50% of waking hours).
* 3 - Symptomatic, >50% in bed, but not bedbound (capable
of only limited self-care, confined to bed or chair 50% or
more of waking hours).
* 4 - Bedbound (completely disabled; cannot carry on any
self-care; totally confined to bed or chair).
* 5 - Death.
A comparison between the Zubrod and Karnofsky scales has been
validated in a large sample of patients:7 6
* Zubrod 0 equals Karnofsky 100; 90-100
" Zubrod 1 equals Karnofsky 80-90; 70-80
* Zubrod 2 equals Karnofsky 60-70; 50-60
" Zubrod 3 equals Karnofsky 40-50; 30-40
* Zubrod 4 equals Karnofsky 20-30;10-20
The WHO has also developed a staging system for HIV disease
based on clinical symptoms, which may be used to guide medical
decision making. This system is effective in resource-poor
communities, where medical facilities are sometimes poorly
equipped, and it is not possible to use CD4 and viral load test results
to determine the right time to begin antiretroviral treatment:
77
* Clinical stage I is asymptomatic HIV with noted persistent
generalized lymphadenopathy.
* Clinical stage II includes moderate unexplained weight loss
(under 10% of presumed or measured body weight),
recurrent respiratory tract infections (sinusitis, tonsillitis,
76. G. Buccheri et al., Karnofsky and ECOG performance status scoring in
lung cancer: a prospective, longitudinal study of 536 patients from a single
institution, 32A EUR. J. CANCER 7, 1135-41 (1996).
77. World Health Organization, Interim WHO Clinical Staging of HIV/AIDS
And HIV/AIDS Case Definitions for Surveillance (2005)
http://www.who.intihiv/pub/guidelines/clinicalstaging.pdf, AVERTing HIV and
Aids, The Different Stages of HIV Infection, http://www.avert.org/stages-hiv-
aids.htm (last visited Oct. 11, 2009).
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otitis media, pharyngitis), herpes zoster, angular cheilitis,
recurrent oral ulceration, papular pruritic eruptions,
seborrhoeic dermatitis, and fungal nail infections.
" Clinical stage III includes unexplained severe weight loss
(over 10% of presumed or measured body weight);
unexplained chronic diarrhea for longer than one month;
unexplained persistent fever (intermittent or constant for
longer than one month); persistent oral candidiasis; oral
hairy leukoplakia; pulmonary tuberculosis; severe bacterial
infections (e.g. pneumonia, emphysema, pyomyositis, bone
or joint infection, meningitis, bacteraemia); acute
necrotizing ulcerative stomatitis, gingivitis or periodontitis;
and unexplained anemia (below 8 g/dl), neutropenia (below
0.5 billion/i) and/or chronic thrombocytopenia (below 50
billion/l).
* Clinical stage IV includes HIV wasting syndrome,
pneumocystis pneumonia, recurrent severe bacterial
pneumonia, chronic herpes simplex infection (orolabial,
genital or anorectal of more than one month's duration or
visceral at any site), oesophageal candidiasis (or candidiasis
of trachea, bronchi or lungs), extrapulmonary tuberculosis,
Kaposi's sarcoma, cytomegalovirus infection (retinitis or
infection of other organs), central nervous system
toxoplasmosis, HIV encephalopathy, extrapulmonary
cryptococcosis including meningitis, disseminated non-
tuberculous mycobacteria infection, progressive multifocal
leukoencephalopathy, chronic cryptosporidiosis, chronic
isosporiasis, disseminated mycosis (extrapulmonary
histoplasmosis, coccidiomycosis), recurrent septicaemia
(including non-typhoidal Salmonella), lymphoma (cerebral
or B cell non-Hodgkin), invasive cervical carcinoma,
atypical disseminated leishmaniasis, and symptomatic HIV-
associated nephropathy or HIV-associated cardiomyopathy.
A specialized medical source statement relating to the specific
symptoms of a special condition could improve the probability of
accurately assessing the condition of an individual with such a
condition. Such a form should allow an individual who has filed for
disability, or a medical source that is treating the individual, to
specifically note medical conditions that allow an adjudicator to more
easily assess functional abilities and general well being. Using HIV
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infection as an example, for ease of completion and consideration, a
form should contain a checklist of various conditions associated with
HIV infection that are relevant to a disability determination the
listing step of the sequential evaluation process. The conditions
listed in the WHO HIV guidelines and the Social Security
Administration's current medical report form for HIV infection
would be helpful in this regard.
An acceptable medical source can also offer an opinion regarding
an individual's physical capacity for work. A section of a specialized
medical source form could ask the source to give an opinion
regarding the ability of the individual to perform sustained work.
This is defined as work on a regular and continuous basis, i.e., eight
hours per day, five days per week, or an equivalent work schedule.
The source could check whether an individual can perform very
heavy, heavy, medium, light, sedentary, less than sedentary work;
and note if the individual is unable to perform even sedentary work.
The source should note the basis for the conclusion, i.e., observations
of the individual, a review of the medical history, or consultation
with other health care providers; and should note the length of time
the individual has been at the listed level of functioning and the
period of treatment.
If the records do not sufficiently clarify the question of whether
the individual is disabled under the Act, an acceptable medical source
can be asked to give an opinion regarding an individual's remaining
work-related capabilities. An acceptable medical source can give an
opinion regarding an individual's judgment, ability to concentrate
and follow instructions, stamina, endurance, mobility inside and
outside the home, emotional volatility, and cognitive difficulties; and
can note whether an individual has trouble with restricted functioning
and needs help with activities of daily living. An acceptable medical
source can also be asked to give an opinion regarding an individual's
symptoms and problems, commenting specifically about the severity
and duration of the symptoms, and whether the severity and duration
of reported symptoms are proportionate to the expected severity and
duration of the medically determinable impairment. The opinion can
report whether the condition of the individual would cause the
individual to miss two or more work days of work per month because
of the individual's conditions; would limit the individual's ability to
reliably adhere to a work schedule; would limit the individual's
ability to perform full time work; or would require the individual to
seek assistance for personal care, shopping, meal preparation, or
household help.
A specialized medical source statement should include queries
regarding the changes the individual has experienced in the way his
or her body is working, pain, body appearance, the ability to perform
self care, appetite, work-like activities, and changes made to
compensate for health changes. The statement should also identify
potential barriers to adherence such as substance abuse, low literacy,
mental health considerations, and lack of prescription drug coverage;
and include a checklist for adverse effects from medications. An
example of such a specialized medical sources statement, relating
specifically to HIV, is available in Appendix A. The form is based
on the Social Security Administration Form SSA-4814-F5, Medical
Report on Adult With Allegation of Human Immunodeficiency Virus
(HIV) Infection, and allows an acceptable medical source to report an
opinion regarding the capacity of an individual to perform sustained
work and the general well being of an individual based on WHO
standards; identify signs, symptoms, and opportunistic infections;
and confirm the severity of symptoms and the length of treatment.
Specialized medical sources statements from acceptable medical
source may be particularly helpful when adjudicators consider cases
relating to special conditions, especially if the statement is from a
treating source who has treated an individual for a sufficient length of
time, and often enough, to be aware of an individual's longitudinal
history and of the overall medical record.7 8 Having such a statement
in the record when considering a case where an individual has a
special condition would allow an adjudicator, at a glance, to take into
78. 20 C.F.R. § 404.1502, § 404.1513; Titles II and XVI: Considering
Opinions and Other Evidence from Sources Who Are Not "Acceptable Medical
Sources" in Disability Claims; Considering Decisions on Disability by Other
Governmental and Nongovernmental Agencies, Social Security Ruling 06-03p,
available at http://www.socialsecurity.gov/OPHome/rulings/di/O1/SSR2006-03-
di-Ol.html. An acceptable medical source may provide medical treatment and
evaluation in an ongoing relationship with an individual involving treatment and
evaluation of a type and frequency that is typical for the condition of the individual.
Under SSA regulations, if the opinion of a treating source on the issues of the
nature and severity of the individual's impairments is well supported by medically
acceptable clinical and laboratory diagnostic techniques, and not inconsistent with
the other substantial evidence in the record, then it will be given controlling weight.
20 C.F.R. § 404.1527(d)(2).
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account an individual's underlying conditions, concomitant
medications, and history of drug intolerance and other issues. Such a
statement would also help an adjudicator consider, in a case where an
individual has HIV infection, whether that individual faces ongoing
limitations despite the selection of a medication regimen that seeks to
maintain viral suppression, improved immune function, and general
well being.
In an Adult Function Report Form (SSA-3373-BK) in a case in
the CAST study, one individual reported no problems with personal
care, no need for special reminders to take medication, no problems
with meal preparation, that he went outside as often as possible, and
no problems with shopping or money. The form contained many "I
don't know" answers. In contrast, a review of the individual's
treating source opinion form, which was specifically crafted by a
representative to focus on HIV, revealed significant issues related to
poor judgment, stamina, endurance, cognitive difficulties, restricted
social functioning, and restricted ability to maintain activities of daily
living. The treating source, in fact, recommended that the individual
needs a home chore provider to assist with cooking, cleaning,
laundry, shopping, and household chores.
Specialized medical source statements used in conjunction with
SSA forms that clarify the limitations and needs of individuals with
special conditions will enhance the ability of ODAR adjudicators to
assess these difficult cases. Creating and updating forms sent to
acceptable medical sources that treat individuals with special
conditions can emphasize to medical sources the need for
clarification to ensure information is not misconstrued and will
ensure that decisions are not made based on apparent inconsistencies.
Given the technological advances now available, the SSA could offer
such a form electronically to make the form more accessible and
easier to complete. This would allow for the improved assessment of
cases of individuals with special conditions.
C. Training, and the Review of Special Conditions Regionally or
Nationally
Transferring cases with special conditions may allow the SSA to
focus resources to enhance the assessment of these cases. The SSA
recently began to transfer cases between offices to redistribute the
workloads and more efficiently process cases. For example, in
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February of 2008, the Office of the Chief Administrative Law Judge
(OCALJ) announced the Service Area Realignment and permanent
case transfers plan. Under this plan, offices with large backlogs
transfer new hearing requests and unscheduled pending cases to
hearing offices that are more quickly able to process the cases. This
plan helps the most heavily impacted hearing offices to more
efficiently processing their workloads. 79 The SSA plans to continue
this transfer activity in fiscal year 2009 and may expand the program
in the future to assist other hearing offices.
The SSA is also addressing the backlog in hearing offices
throughout the nation with National Hearing Centers. During fiscal
year 2008, the National Hearing Center in Falls Church, Virginia,
assisted the Chicago Region by holding hearings on Detroit and
Cleveland cases. The strategy behind National Hearing Centers is to
address the hearings backlog and reduce case processing time by
increasing adjudicatory capacity. In fiscal year 2009, the Falls
Church National Hearing Center will assist the Flint and Indianapolis
hearing offices. In a statement to the United States House of
Representative Committee on Ways and Means on September 16,
2008, Frank Cristaudo, Chief Administrative Law Judge of the SSA,
confirmed the positive feedback from individuals using that National
Hearing Center.80 To further address the hearing backlog, the SSA is
building additional national hearing centers throughout the country,
including one that opened recently in Albuquerque, New Mexico.81
Similarly, the SSA could increase the effective consideration of
cases involving special conditions by focusing the consideration of
79. For example, prior to the implementation of this plan, the number of cases
pending in the Chicago Region exceeded 1,000 cases per AL. In contrast, cases
pending in the Boston Region were less than 300 per ALJ. Transferring the cases
allowed the Chicago Region to transfer out over 25,000 cases, lowering the
pending case number to fewer than 800 per ALJ in the Chicago Region for fiscal
year 2008.
80. Testimony Before the Subcomm. on Social Security of the H. Comm. on
Ways and Means, 110th Cong., (2008) (statement of Frank A. Cristaudo, C.A.L.J.,
Office of Disability Adjudication and Review, Social Security Administration),
available at
http://waysandmeans.house.gov/hearings.asp?formmode=printfriendly&id=7384
81. Press Release, Commissioner Astrue & Senator Bingaman, Social
Security Administration, Tour New National Hearing Center in Albuquerque (April
15, 2009) http://www.socialsecurity.gov/pressoffice/pr/albuquerqueNHC-pr.htm.
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these cases to a limited number of hearing offices throughout a
region or the nation. Currently, each hearing office receives cases
based on geographical region and the physical address of the
individual seeking benefits. Adjudicators consider a wide variety of
conditions, and very often without the benefit of the medical
expertise of a physician during the hearing process. Adjudicators
may complete determinations on certain conditions on a regular
basis-disorders of the back, affective disorders, diabetes, and
asthma come to mind-but may consider other conditions only a few
times throughout the course of a fiscal year. There are a large
number of medical conditions, both physical and mental; voluminous
medical records accumulated by the time a case reaches the hearing
level; and a push each year for adjudicators and other SSA
employees to increase their productivity.
Allowing the review of such cases regionally or nationally would
allow a limited number of adjudicators with expertise on certain
conditions to process those cases more effectively than could be done
with less expertise in a general hearing office. HIV infection is an
example of a special condition that is complex: it affects individuals
differently, and has a wide and evolving array of treatment
modalities. Thus, appropriate training and experience, as well as
continuing medical education, are important components in
adequately considering cases where individuals have a special
condition such as HIV infection.82
82. A specialty office or offices considering special conditions would benefit
from specialized training and guidance on the conditions under consideration as
well as, at the outset, a review of the rules regarding the weight given to treating
physician opinions, the role of non-physician evidence, the evaluation of mental
impairments, pain, and other subjective symptoms as they relate to H1V. A review
could include information on relevant Social Security Rulings such as 85-15 (non-
exertional impairments/capability to work), 99-2 (chronic fatigue), 02-2 (interstitial
cystitis), 03-2 (reflex sympathetic dystrophy), 06-3 (evidence that must be used to
establish medically determinable impairments and evidence to be considered to
evaluate the nature and severity of the impairment). Training could also include
guidance related to HIV psychiatry. Clinical experience and research provide
substantial evidence that HIV directly infects the brain. The involvement of
psychiatrists in the diagnosis and treatment of individuals with HIV/AIDS is
important because of the prevalence of HIV-related neuropsychiatric complications
and psychiatric comorbidity for individuals with H1V. American Psychiatric
Association, HIV Psychiatry: APA H1V Program Overview,
http://www.psych.org/Resources/OfficeofHlVPsychiatry.aspx. Helpful training for
ODAR adjudicators with specialized knowledge can more easily
understand a complicated disorder where diagnoses may be based
more on symptom-based, clinical observation than test results. Just
as primary care providers without HIV experience, such as those in
rural areas, should identify experts in the region who will provide
consultation when needed, SSA adjudicators considering these
special cases should be able to seek consultation when needed. HIV
is a lifelong infection that can require treatment through several
stages of growth and development. Thus, cases in which HIV
infection is a condition require flexibility to appropriately consider
individuals who-while they share the same condition-may have
fundamental differences with unique biomedical and psychosocial
considerations.
With its new electronic system, the SSA can automatically and
precisely organize cases for faster processing. Functioning in the
electronic environment allows the SSA to store data in a centralized
and secure repository, reduce the time it takes to send and receive
information, minimize manual actions, eliminate the need to handle
and store voluminous paper files, automatically create exhibit lists,
provide online access to hearing notices, reduce the possibility of
processing and closing a case without resolving outstanding issues,
automate the mailing of decisions, and facilitate review of the
evidence. The system would easily accommodate the consideration
of cases with special conditions on a regional or national basis, which
could result in a more efficient and effective process for handling
these cases.
The SSA recently reinstituted an attorney adjudicator program,
which allows the SSA's most experienced ODAR attorneys to spend
a portion of their time making disability decisions in cases where
enough evidence exists to issue a favorable decision without waiting
for a hearing. Allowing qualified ODAR attorneys to assist with the
processing of cases with special conditions on a regional or national
basis would help to concentrate the knowledge for the special cases
with certain capable individuals. It would also allow the ODAR
Administrative Law Judges to focus on their regular docket of
pending cases.
specific conditions is already available to ODAR adjudicators at
http://training.ba.ssa.gov/ot/.
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An example of how such a process might be effective is the
Chicago Region's Office of Quality Performance (OQP) screening
unit. The unit began screening ODAR cases in March of 2008,
focusing on cases with characteristics such as an individual's age,
basis for denial at the initial determination level, and condition. The
goal of screening is to identify possible on-the-record decisions. The
unit, trained by the Chicago ODAR Regional Office, is staffed with
ten employees and reviews cases from backlogged Michigan offices.
An ODAR Senior Attorney sits with case examiners and serves as a
resource person and issues decisions. The Chicago ODAR Regional
Office also provides ongoing mentoring for the examiners, as well as
consultation on individual cases. Between March and mid-
September of 2008, the screening unit reviewed over 880 cases,
issuing fully favorable decisions in 198, or 22.5%, of the cases.
Other OQP screening units have since been established throughout
the country.
Modifications to the case processing system to allow for the
review of special conditions regionally or nationally could allow for
the effective, efficient processing of cases with special conditions.
Allowing adjudicators with specific knowledge of special conditions
could further enhance the decision making process. Such
modifications could prevent resistance to or delayed favorable
disability decisions resulting from knowledge deficits, stigma, or
differences in evaluation styles, which would benefit individuals with
special conditions who are seeking disability.
D. Consider Ongoing Advances in Technology and Treatment
While highly active antiretroviral therapy (HAART) can reduce
an individual's viral load and may delay the progression of HIV, HIV
persists even in individuals who are receiving aggressive
antiretroviral therapy and have no readily detectable HIV in their
blood. Factors such as age, genetic differences among individuals,
the level of virulence on an individual strain of virus, and co-
infection with other microbes may all affect the rate and severity of
disease progression. However clearly drugs that fight infections
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associated with HIV infection have improved and prolonged the lives
of individuals infected with HIV.83
Current treatment regimens involve taking several antiretroviral
drugs each day from at least two different classes, some of which
result in unpleasant side effects such as nausea, diarrhea, and
vomiting. Complicated drug regimens, combined with significant
side effects, may results in low adherence to the regimen. Also,
antiretroviral drugs may cause more serious medical problems
including metabolic changes such as abnormal fat distribution,
abnormal lipid and glucose metabolism, and bone loss. Thus
ongoing studies seek simpler, less toxic, and more effective drug
regimens.84 New drugs in development to treat HIV infection
include new protease inhibitors and more potent, less toxic RT
inhibitors. Other drugs are in development and are being designed to
interfere with entirely different steps in the virus' lifecycle. These
new categories of drugs include:
" Entry inhibitors that interfere with HIV's ability to enter
cells.
" Integrase inhibitors that interfere with HIV's ability to insert
its genes into a cell's normal DNA.
" Assembly and budding inhibitors that interfere with the final
stage of the HIV life cycle, when new virus particles are
released into the bloodstream.
* Cellular metabolism modulators that interfere with the
cellular processes needed for HIV replication.
* Gene therapy that uses modified genes inserted directly into
cells to suppress HIV replication. These cells are designed
to produce T cells that are genetically resistant to HIV
infection.
In addition, scientists are exploring whether immune modulators
help boost the immune response to the virus and whether they may
83. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,
DEPARTMENT OF HEALTH AND HUMAN SERVICES, How HIV CAUSES AIDS, at 5-6
(2004), available at
http://www3.niaid.nih.gov/topics/HIVAIDS/Understanding/How+HIV+Causes+AI
DS/.
84. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,
DEPARTMENT OF HEALTH AND HUMAN SERVICES, TREATMENT OF HIV INFECTION
(2007), http://www.niaid.nih.gov/factsheets/treat-hiv.htm.
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make existing anti-HIV drugs more effective. Therapeutic vaccines
also are being evaluated for this purpose and could help reduce the
number of anti-HIV drugs needed or the duration of treatment.8 5
Antiretroviral therapy for treatment of HIV has improved steadily
since the introduction of combination therapy. New drugs offer new
mechanisms of action; improvements in potency; activity against
multi-drug resistance viruses; and better dosing, convenience, and
tolerability. 86 Adherence to antiretroviral therapy strongly correlates
with HIV viral suppression, reduced rates of resistance, and increase
in survival, and an improved quality of life.87 As treatment for HIV
infection evolves, the availability of new treatment agents and new
clinical data may change therapeutic options and preferences for
people with HIV infection. Guidelines thus should be updated
frequently, and adjudicators must exercise good judgment in making
decisions tailored to unique individual circumstances and in the
ongoing review of cases to measure the success of any treatment
received after a favorable disability decision.
VIII. CONCLUSION
In the 2008 fiscal year, requests for ODAR hearings increased
and the agency lost experienced administrative law judges through
attrition. During that same year, the SSA processed 575 thousand
hearings and more than 2.6 million initial disability claims.88 Despite
ongoing challenges, the SSA made significant progress in
implementing its initiatives to eliminate the hearing backlog and
prevent its recurrence. By mid-year in fiscal year 2008, ODAR
reported accomplishments that include a reduced number of aged
cases, opening the National Hearing Center, hiring additional
85. Id.
86. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,
DEPARTMENT OF HEALTH AND HUMAN SERVICES, GUIDELINES FOR THE USE OF
ANTIRETROVIRAL AGENTS IN HIV-1-INFECTED ADULTS AND ADOLESCENTS 1
(2008), available at
http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf.
87. Id. at 92.
88. SSA's Performance and Accountability Report for (FY) Fiscal Year 2008:
Management's Discussion and Analysis, Social Security Administration 12,
available at http://www.ssa.gov/finance/.
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administrative law judges, transitioning seventy-five percent of the
pending workload to electronic folders, and implementing a service
area realignment plan. Regarding the Compassionate Allowances
initiative, the Office of Retirement and Disability Policy developed
and expanded the use of automated screening tools and continued to
update agency rules and regulations to reflect advances in medical
science. 89
In 2009, the SSA has continued to make significant progress in
reducing its backlog of cases at the ODAR hearing level. 90 The SSA
has continued to appeal to medical professionals and organizations
for ways to improve its criteria for evaluating diseases and conditions
so that the criteria reflect the real difficulties faced by people living
with these diseases and conditions. On August 7, 2009, Deputy
Commissioner David V. Foster confirmed in an agency broadcast
that the SSA expects increased initial disability claims in 2010, and
that ODAR is expected to expand its capacity to handle the additional
projected receipts due to the recession. Mr. Foster noted further,
however, that the disability backlog has decreased over 19,000 cases
from the start of the year.
The SSA has made recent progress to improve the disability
process for individuals with special conditions. Given the various
strategies and potential future improvements available, the challenge
for the SSA is to select the best options for ODAR hearing
adjudicators, to best serve individuals who have filed for disability.
The complexity of the conditions and the importance of new
technology as it relates to treatment as well as the handling of cases
at the ODAR hearing level require the SSA to seek novel ways to
improve the process. Modifications will improve the process by
which individuals are served at the hearing level. Ongoing energy
directed in this way will further the mission of providing timely and
89. OFFICE OF DISABILITY ADJUDICATION AND REVIEW, SOCIAL SECURITY
ADMINISTRATION, PLAN TO ELIMINATE THE HEARING BACKLOG AND PREVENT ITS
RECURRENCE, SEMIANNUAL REPORT 2 (Fiscal Year 2008), available at
http://www.ssa.gov/disability/Semiannual-Report-FY08.pdf.
90. For detailed information on a state-by-state basis on the progress that the
SSA has made toward the reduction in cases at the ODAR hearing level, see
Hearings Backlog Reduction Update Booklets, Fiscal Year 2009, Second Quarter,
available at http://www.socialsecurity.gov/appeals/congressional-booklets.html.
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legally sufficient hearings and decisions to individuals, and greatly
and positively affect the individuals involved in these cases.
IX. APPENDIX A: SAMPLE FORM FOR HEALTH CARE PROVIDER - HIV
INFECTION
Date:_ Claimant's Name: SSN:
Claimants's Address: DOB:
Health Care Provider Name (please print):
Health Care Provider Address and Phone Number:
You are asked to give an opinion and information to assist the
Social Security Administration in making a disability determination.
In evaluating your patient's claim for disability benefits, we review
the medical record for evidence of the presence and severity of the
patient's medically determinable impairments. Where the medical
record is not sufficiently clear, additional statements from treating
health care providers such as you are especially relevant evidence
upon which we can rely in determining eligibility for disability
benefits. Your opinions and statements are important for our review,
and we are grateful for your thoughtful and thorough consideration of
these questions. Please be aware that your statements are only one
part of the evidence that we consider in evaluating your patient's
claim, and will be evaluated along with other evidence to assess your
patient's medical condition and functional abilities. Your statements
alone are not sufficient to cause us to either grant or deny benefits.
But without your statements, we are unable to fully evaluate your
patient's application. Thank you for your assistance.
You are asked to give an opinion regarding your patient's ability
to performed sustained work. Sustained work is defined as work a
regular and continuous basis, i.e., eight hours per day, five days per
week, or an equivalent work schedule:
Very Heavy Work. Frequent lifting and carrying of objects
weighing 50 pounds or more. Requires standing or walking
up to six hours of an eight-hour workday. Physical demands
are in excess of those in Heavy Work category.
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-Heavy Work. Frequent lifting or carrying of objects up to
50 pounds. Requires standing or walking up to six hours of an
eight-hour workday. Physical demand requirements are in
excess of those for Medium Work category.
_Medium Work. Frequent lifting or carrying of objects up to
25 pounds. Requires standing or walking up to six hours of an
eight-hour workday. Physical demand requirements are in
excess of those for Light Work category.
.Light Work. Frequent lifting or carrying of objects up to 10
pounds. Even though weight lifted may be very little, light
work requires a good deal of walking or standing, off and on,
for a total of approximately six hours in an eight-hour
workday. To be considered capable of performing a full or
wide range of light work, you must have the ability to do
substantially all of these activities. If someone can do light
work, that person could also do sedentary work, unless there
are additional limiting factors such as loss of fine dexterity or
inability to sit for long periods of time.
_Sedentary Work. Lifting objects up to 10 pounds at a time
and occasionally lifting or carrying articles such as docket
files, ledgers, and small tools, Being on one's feet is required
occasionally. Although a sedentary job is defined as one that
involves sitting, a certain amount of standing and walking is
often necessary in carrying out job duties. Jobs are sedentary
if walking and standing are required occasionally, but no
more than two hours per eight-hour workday.
_Unable to perform even sedentary work on a regular and
continuous basis, i.e., eight hours per day, five days per week,
or an equivalent work schedule.
How long have you treated the patient?
How long has your patient's condition resulted in this level of
functioning?
The Social Security Administration understands that HIV
infection may result in opportunistic infection, as well as signs and
symptoms that are related to or traceable to the disease or its
treatment, but that are not accurately considered to be opportunistic
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infection. Some of those signs and symptoms include severe fatigue,
fever, malaise, weight loss, pain, night sweats, nausea, vomiting,
headaches, insomnia, or diarrhea. Further, the Social Security
Administration recognizes that HIV impacts the mental, emotional
and cognitive health of those who are infected, and that individuals
with HIV infection may suffer mental and emotional limitations in
addition to physical limitations. Please identify signs or symptoms of
HIV infection or its treatment that your patient exhibits or has been
affected by, the estimated frequency of occurrence in the same 1-year
period, and the approximate date of each episode. In forming your
answer to this question, please consider your patient's condition from
[date] to the present.
Please note further if your patient has the following:
__ Marked Limitation of Activities of Daily Living
_ Marked Limitation in Maintaining Social Functioning
_ Marked Limitation in Completing Tasks in a Timely Manner
due to Deficiencies in Concentration, Persistence, or Pace
Regarding his or her mental condition, please note specifically if
your patient has trouble with:
- Responding appropriately to a task or problem
- Racing thoughts
- Understanding instructions
Poor focus
- Processing instructions and performing accordingly
- Sleep disturbance
- Following appropriate steps to complete a task
- Memory problems
- Concentrating on a task until it is completed
Stamina/endurance
- Completing tasks in a reasonable amount of time
Affective disorders
- Poor judgment
Emotional volatility
Social isolation/restricted social functioning
- Vision problems
- Being easily overwhelmed
- Irritability
- Cognitive difficulties or loss of cognitive abilities
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__ Dementia
__ Restricted daily activities/mobility/balance
__ Panic attacks/anxiety
Has your patient had any of these medical problems? Please note
treatment dates.
__ BACTERIAL INFECTIONS (14.08A)
1. __ MYCOBACTERIAL INFECTION, (e.g., caused by M. avium-
intracellulare, M. kansasii, or M. tuberculosis), at a site
other than the lungs, skin, or cervical or hilar lymph
nodes, or pulmonary tuberculosis resistant to treatment; or
2. _ NOCARDOSIS; or
3. _ SALMONELLA BACTERIMIA, recurrent non-typhoid;
or
4. __ MULTIPLE OR RECURRENT BACTERIAL INFECTION(S),
including pelvic inflammatory disease, requiring
hospitalization or intravenous antibiotic treatment 3 or
more times in a 1-year period.
__ FUNGAL INFECTIONS (14.08B)
1. __ ASPERGILLOSIS; or
2. __ CANDIDIASIS involving the esophagus, trachea, bronchi,
or lungs, or at a site other than the skin, urinary tract,
intestinal tract, or oral or vulvovaginal mucous
membranes; or
3. __ COCCIDIOIDOMYCOSIS, at a site other than the lungs or
lymph nodes; or
4. __ CRYPTOCOCCOSIS, at a site other than the lungs (e.g.,
cryptococcal meningitis); or
5. __ HISTOPLASMOSIS, at a site other than the lungs or lymph
nodes
6. _ MUCORMYCOSIS; or
7. - PNEUMOCYSTIS PNEUMONIA or extrapulmonary
Pneumocystis infection.
__ PROTOZOAN OR HELMINTHIC INFECTIONS (14.08C)
1. CRYPTOSPORIDIOSIS, ISOSPORIASIS, OR
MICROSPORIDIOSIS, with diarrhea lasting for 1 month or
longer; or
2. __ STRONGYLOIDIASIS, extra-intestinal; or
3. __ TOXOPLASMOSIS of an organ other than the liver, spleen,
or lymph nodes.
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__ VIRAL INFECTIONS (14.08D)
1. - CYTOMEGALOVIRUS DISEASE, at a site other than the
liver, spleen, or lymph nodes; or
2. - HERPES SIMPLEX VIRUS causing mucocutaneous
infection (e.g., oral, genital, perianal) lasting for 1 month
or longer; or infection at a site other than the skin or
mucous membranes (e.g., bronchitis, pneumonitis,
esophagitis, or encephalitis); or disseminated infection; or
3. - HERPES ZOSTER, disseminated or with multideratomal
eruptions that are resistant to treatment; or
4. __ PROGRESSIVE MUTIFOCAL LEUKOENCEPHALOPATHY.
__ MALIGNANT NEOPLASMS (14.08E)
1. __ CARCINOMA OF THE CERVIX, invasive, FIGO stage II
and beyond; or
2. __ KAPOSI'S SARCOMA with extensive oral lesions; or
involvement of the gastrointestinal tract, lungs, or other
visceral organs; or
3. __ LYMPHOMA (e.g., primary lymphoma of the brain,
Burkitt's lymphoma, immunoblastic sarcoma, other non-
Hodgkin's lymphoma, Hodgkin's disease); or
4. _ SQUAMOUS CELL CARCINOMA OF ANAL CANAL OR
ANAL MERGIN.
__ SKIN OR MUCOUS MEMBRANES (14.08F)
CONDITIONS OF THE SKIN OR MUCOUS MEMBRANES, with
extensive fungating or ulcerating lesions not responding
to treatment (e.g., dermatological conditions such as
eczema or psoriais, vulvovaginal or other mucosal
Candida, condyloma caused by human Papillomavirus,
genital ulcerative disease).
__ HIV ENCEPHALOPATHY (14.08G)
HIV ENCEPHALOPATHY, characterized by cognitive or
motor dysfunction that limits function and progresses.
__ HIV WASTING SYNDROME (14.08H)
HIV WASTING SYNDROME, characterized by involuntary
weight loss of 10 percent or more of baseline (computed
based on pounds, kilograms, or body mass index (BMI))
or other significant involuntary weight loss; with either
chronic diarrhea with 2 or more loose stools per day
lasting for 1 month or longer; or chronic weakness and
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documented fever greater than 38'C (100.4°F) for the
majority of 1 month or longer.
_ DIARRHEA (14.081)
DIARRHEA, lasting for 1 month or longer, resistant to
treatment, and requiring intravenous hydration,
intravenous alimentation, or tube feeding.
_ INFECTIONS RESISTANT TO TREATMENT OR REQUIRING
HOSPITALIZATION OR INTRAVENOUS TREATMENT 3 OR MORE TIMES IN
A 12-MONTH PERIOD (14.08J)
1. __ SEPSIS; or
2. __ MENINGITIS; or
3. __ PNEUMONIA; or
4. __ SEPTIC ARTHRITIS; or
5. __ ENDOCARDITIS; or
6. _ SINUSITIS, documented by appropriate medically
acceptable imaging.
Are the patients' complaints attributable to one or more medically
determinable impairments? YES /No
Is the severity and duration of the symptoms proportionate to the
expected severity and duration of the medically determinable
impairments? YES / No
Is the severity of the symptoms and the effects on function
consistent with the total medical and nonmedical evidence, including
statements by the patient and others, your observations of the patient,
and the patient's alteration of behavior or habits? YES / No
Does the patient need a home care provider for help with personal
hygiene or activities of daily living? YES / No
You are asked to give an opinion regarding your patient's
performance status measures help to quantify his or her general well
being. At 100, a person is able to carry out normal activity and can
work, and needs no special care. At 70, a person is unable to work,
but is able to live at home, care for most personal needs, and requires
a varying degree of assistance. At 40, a person is unable to care for
himself, and requires the equivalent of institutional or hospital care.
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- 100 - normal, no complaints, no signs of disease
- 90 - capable of normal activity, minor signs or symptoms
of disease
- 80 - normal activity with effort; some signs or symptoms
of disease
- 70 - cares for self; unable to carry on normal activity or
to do active work
- 60 - requires occasional assistance but is able to care for
most needs
- 50 - requires considerable assistance and frequent
medical care
40 - disabled; requires special care and assistance
30 - severely disabled; hospitalization is indicated
although death not imminent
20 - very sick; hospitalization necessary; active
supportive treatment necessary
- 10 - moribund; fatal processes progressing rapidly
0 - dead
Sources that form the basis of your conclusion:
My observations of the patient
- My review of the patient's medical history
Consultation with other treating health care providers
Statements and complaints of the patient, whom I believe
to be credible
- Other (please describe)
Comments:
SIGNATURE:
PRACTICE AREA:
PRINTED NAME:
DATE:
